Driving Drug-CDx Partnerships for Scalable Precision Medicine Access

Empowering Timely & Affordable Drug-Diagnostic Access Across APAC Through Harmonized Trial Management, Policy Shaping, & Testing Adoption

With rising demand for targeted therapies and testing access, the Asia-Pacific region is becoming a rising player in the co-development and commercialization of drug-diagnostic strategies. In under a year, Singapore has accelerated public-private partnerships to scale genomic testing, China has expanded national reimbursement for liquid biopsies, and Japan has refined its regulatory framework for companion diagnostic approvals.   

Returning for its second year, the World Liquid Biopsy & Companion Diagnostics Summit APAC will unite 100+ leaders across biopharma, diagnostics, regulation, and healthcare to drive the co-development and commercialization of affordable, scalable, and timely testing solutions. 

Spanning oncology to neurology, chronic and rare diseases, join this APAC-dedicated forum addressing the full drug-diagnostic co-development journey, where precision partnerships are formed, regional strategies aligned, and precision medicine innovation accelerated for improved patient access across the region. 

This forum presents a great opportunity to get to know the latest advances in precision medicine and connected with leading industrial peers. The networking part of this event was extremely helpful for us to reach other APAC peers in a short time.

Past Attendee, Bristol Myers Squibb  

bristol myers squibb logo

The quality of the speakers and delegates was very high, with an emphasis on diagnostic and pharmaceutical development.

Past Attendee, Engine Biosciences 

engine biosciences

Very exciting APAC forum, where people are willing to share their precision medicine thoughts and insights with attendees, the network sections are very useful.

Past Attendee, OBI Pharma 

OBI Pharma logo

Explore the Full Event Guide

议程    |    議題    |    Agenda

  • Free* to Attend for Biopharma & Academia
  • Asia-Pacific’s Only Biomarker & Companion Diagnostic Forum
  • Solid Tumor & Liquid Biopsy Biomarker Strategies
  • Oncology, Neurological & Rare Disease Case Studies
  • Exclusive Networking & Partnerships with Global Decision Makers
brochure cover

What To Expect

您会看到什么    |    見どころ    |    Apa yang Diharapkan

100+

Attendees from Biopharma & Diagnostic Solutions

20+

Leading Regional Case Studies

68%

New Presenting Organizations

7+

Hours of Dedicated Networking

6+

Countries Represented

Official Partners

合作伙伴    |    パートナー    |    Rakan Kongsi

brochure cover

Attending Companies Include

与会公司    |    参加企業    |    Syarikat yang Hadir

AstraZeneca
johnson & johnson
takeda logo
TUV SUD lgoo
Chugai pharmaceuticals
Astellas Logo
Gilead logo
AbbVie logo
FIND logo

Explore Related Events

conference audience
Explore the Agenda

Gain first-hand insights into the latest regional and global breakthroughs in biomarkers, clinical development, and CDx approvals. Explore APAC’s most innovative precision medicine advances through a packed agenda of expert-led sessions and exclusive drug-diagnostic partnership discussions 

Booth networking
Partner With Us

Position your brand alongside leading global and APAC-local CDx and IVD innovators to stay at the forefront of precision medicine partnerships and commercialization across Asia-Pacific 

Conference audience
Join Biopharma Experts

Join the region’s only precision medicine community for dynamic and high-impact conversations across diverse precision medicine therapy areas and modalities